| Application no. and date | 16188301.2 (espacenet) (Federated) (European Patent Register), 20160912 | | Patent/reg. no. and date | DK/EP 3293201, 20201104 | | Publication date | 20180314 | | Priority no. and date | | | EP pub. no. and date |
EP 3293201 20180314 | | Effective date | | | Applicant/owner | Targovax Oy, Lars Sonckin kaari 14
02600 Espoo, FI | | Applicant ref. no. | V51079DK00 | | Inventor | RANKI, Tuuli, Urpukuja 1
11130 Riihimäki, FI,
KURYK, Lukasz, Kalevankatu 38 A 7
00180 Helsinki, FI,
PESONEN, Sari, Porslahdentie 23 G 34
00980 Helsinki, FI,
HAAVISTO, Elina, Svinhufvudintie 11 C 21
00570 Helsinki, FI,
VUOLANTO, Antti, Käpyläntie 26
02880 Veikkola, FI,
JÄDERBERG, Magnus, 46 Mountfield Road
N3 3NP London, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 35/761 (2015.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 14/535 (2006.01) , C07K 16/28 (2006.01) , A61K 39/00 (2006.01) | | Title | Kombinering af adenovirus og checkpoint-inhibitorer til behandling af cancer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
